Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.
Lee YH, Seo D, Choi KJ, Andersen JB, Won MA, Kitade M, Gómez-Quiroz LE, Judge AD, Marquardt JU, Raggi C, Conner EA, MacLachlan I, Factor VM, Thorgeirsson SS.
Lee YH, et al.
Cancer Res. 2014 Sep 1;74(17):4752-61. doi: 10.1158/0008-5472.CAN-13-3531. Epub 2014 Jun 23.
Cancer Res. 2014.
PMID: 24958469
Free PMC article.